PAXALISIB
UNII P5DKZ70636

Substance Identification & Data

This profile provides standardized clinical and technical data for Paxalisib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P5DKZ70636.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1382979-44-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P5DKZ70636

CAS Registry Number

1382979-44-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PAXALISIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H22N8O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LGWACEZVCMBSKW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C116877

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

57384863

Unique identification number in the NCBI database of chemical substances.

INN ID

11102

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-149

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CN(c2nc(-c3cnc(N)nc3)nc4c2nc5C(C)(C)OCCn45)CCO1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Paxalisib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.